| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/04/2009 | US7569363 Modified Cry3A toxins and nucleic acid sequences coding therefor |
| 08/04/2009 | US7569362 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing |
| 08/04/2009 | US7569360 Comprising mutant glutathione synthetase; fractionation; heat treatment; foods, beverages |
| 08/04/2009 | US7569223 Isolated polypeptide is amino acid sequence; lytic enzyme comprises a first isolated amino acid sequence homolog; In vitro Killing Assay; In vivo Nasal Infection Assay |
| 08/04/2009 | US7569215 Mutant interleukin-2 (IL-2) polypeptides |
| 08/04/2009 | CA2398744C Biosynthetic carbohydrate-deficient transferrin references |
| 08/04/2009 | CA2365281C Human antibodies that bind human il-12 and methods for producing |
| 08/04/2009 | CA2194673C A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 07/30/2009 | WO2009094485A1 Methods and organisms for utilizing synthesis gas or other gaseous carbon sources and methanol |
| 07/30/2009 | WO2009093962A1 Multifunctional tags |
| 07/30/2009 | WO2009093118A1 Cell surface display of proteins |
| 07/30/2009 | WO2009023773A9 Galactokinase inhibitors |
| 07/30/2009 | WO2008145013A8 Fusion protein comprising targeting peptide of cd13 and lidamycin |
| 07/30/2009 | WO2008085543A8 Multimeric elp fusion constructs |
| 07/30/2009 | WO2008079359A8 Human antibodies that bind human il-12 and methods for producing |
| 07/30/2009 | WO2008017734A8 Polymyxin derivatives and uses thereof |
| 07/30/2009 | WO2007092932A8 Bivalent erbb ligand binding molecules and methods for their preparation and use |
| 07/30/2009 | WO2007083226A8 Method for selecting a peptide or polypeptide which binds to a target molecule |
| 07/30/2009 | US20090193529 Method for Generating Antibodies |
| 07/30/2009 | US20090192294 Magi polynucleotides, polypeptides, and antibodies |
| 07/30/2009 | US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides |
| 07/30/2009 | US20090192291 Production of homotrimeric fusion proteins |
| 07/30/2009 | US20090192088 Vascular Endothelial Growth Factor 2 |
| 07/30/2009 | US20090192085 FKBP-L And Uses Thereof |
| 07/30/2009 | US20090192073 Method for producing insulin analogs having a dibasic b chain terminus |
| 07/30/2009 | US20090191640 Methods of Screening for Atherosclerosis |
| 07/30/2009 | US20090191600 Via L-aspartic acid- alpha,beta-diester and L-phenylalanine using enzyme that has ability to selectively link L-phenylalanine to alpha -ester site of L-aspartic acid- alpha,beta-diester through peptide bond/nucleophilic attack; easy, high yield and inexpensively without going through a complex synthesis |
| 07/30/2009 | US20090191592 Glycoengineered, recombinant antibody |
| 07/30/2009 | US20090191591 Taurine Transporter Gene |
| 07/30/2009 | US20090191590 Signal Peptide for Producing a Polypeptide |
| 07/30/2009 | US20090191589 Process for producing dipeptides |
| 07/30/2009 | US20090191588 Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav |
| 07/30/2009 | US20090191587 Method for high-level secretory production of protein |
| 07/30/2009 | US20090191586 Enzyme expression methods and compositions |
| 07/30/2009 | US20090191572 Imaging, diagnosis and treatment of disease |
| 07/30/2009 | US20090191569 Mammalian Cytokines; Related Reagents |
| 07/30/2009 | US20090191560 Mutant dna polymerases and uses therof |
| 07/30/2009 | US20090191550 Diagnosis of whipple's disease |
| 07/30/2009 | US20090191536 Rabbit monoclonal antibodies to hepatitis B surface antigens and methods of using the same |
| 07/30/2009 | US20090191241 Method and compositions for immunization with the pseudomonas v antigen |
| 07/30/2009 | US20090191238 Method for producing yeast expressed HPV types 6 and 16 capsid proteins |
| 07/30/2009 | US20090191234 Vaccine |
| 07/30/2009 | US20090191225 Fusion proteins; homogeneous purity, and unaltered affinity, and can be produced in high yields without the requirement of extensive purification; stable in serum to allow in vivo applications |
| 07/30/2009 | US20090191221 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same |
| 07/30/2009 | US20090191213 Compositions and methods for regulating NK cell activity |
| 07/30/2009 | US20090191211 METHODS FOR DAMAGING CELLS USING EFFECTOR FUNCTIONS OF ANTI-EphA4 ANTIBODIES |
| 07/30/2009 | US20090191209 Methods and compositions for targeting polyubiquitin |
| 07/30/2009 | US20090191199 Glycoengineered, recombinant antibody |
| 07/30/2009 | US20090191192 Humanized anti-ccr2 antibodies and methods of use therefor |
| 07/30/2009 | US20090191190 Anti-ABeta Globulomer Antibodies, Antigen-Binding Moieties Thereof, Corresponding Hybridomas, Nucleic Acids, Vectors, Host Cells, Methods of Producing Said Antibodies, Compositions Comprising Said Antibodies, Uses Of Said Antibodies And Methods Of Using Said Antibodies |
| 07/30/2009 | US20090191187 Antibodies against interleukin-1 receptor and uses thereof |
| 07/30/2009 | US20090191178 Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses Thereof |
| 07/30/2009 | US20090191117 Anti-Integrin Antibodies, Compositions, Methods and Uses |
| 07/29/2009 | EP2083084A1 Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
| 07/29/2009 | EP2083079A1 Apo-2DcR |
| 07/29/2009 | EP2083017A1 Antibody having enhanced adcc activity and method for production thereof |
| 07/29/2009 | EP1572897B1 Ordered biological nanostructures formed from chaperonin polypeptides |
| 07/29/2009 | EP1483282B1 RIBOZYMES WITH BROAD tRNA AMINOACYLATION ACTIVITY |
| 07/29/2009 | EP1409984B1 Methods and reagents for detecting endotoxin |
| 07/29/2009 | EP1293567B1 Ligand to gpr8 and dna thereof |
| 07/29/2009 | EP1292676B1 Mutation associated with epilepsy |
| 07/29/2009 | EP1105360B1 Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules |
| 07/29/2009 | EP1086223B1 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 07/29/2009 | EP1073463B1 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation |
| 07/29/2009 | EP1002110B2 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 07/29/2009 | EP0980434B1 Intracellular production of hepatitis c e2 truncated polypeptid |
| 07/29/2009 | CN101495645A Method for purifying proteins |
| 07/29/2009 | CN101495644A 密码子优化方法 Codon optimization |
| 07/29/2009 | CN101492496A A method for identification, isolation and production of antigens to a specific pathogen |
| 07/29/2009 | CN100519753C Recombinant microorganism |
| 07/29/2009 | CN100519749C Agonist anti-TRK-C monoclonal antibodies |
| 07/29/2009 | CN100519735C Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| 07/29/2009 | CN100519584C Antibodies against fibroblast growth factor 23 |
| 07/28/2009 | US7566813 Transgenic soybean seeds exhibiting an oil composition comprising 55 to 80% by weight oleic acid, 10 to 40% by weight linoleic acid, 6% or less by weight linolenic acid, and 2 to 8% by weight saturated fatty acids for use in ehancing applicability in food, biodiesel and biolube markets |
| 07/28/2009 | US7566777 Genes encoding hormone and lytic peptides |
| 07/28/2009 | US7566776 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| 07/28/2009 | US7566774 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 07/28/2009 | US7566770 Humanized collagen antibodies and related methods |
| 07/28/2009 | US7566767 Synthetic peptides and methods of use for autoimmune disease therapies |
| 07/28/2009 | US7566765 Heterocyclic compounds containing a nine-membered carbon-nitrogen ring |
| 07/28/2009 | US7566764 Truncated BARD1 protein, and its diagnostic and therapeutic uses |
| 07/28/2009 | US7566694 Anti-pathogen treatments |
| 07/28/2009 | US7566567 nontumorigenic, virally-immortalized human hepatocyte cell lines, that can be maintained in serum-free media, and produce endogenous plasma proteins, such as albumin, alpha -1 antitrypsin, blood clotting factors VIII and IX, |
| 07/28/2009 | US7566563 Compositions and methods for manipulating carbon flux in cells |
| 07/28/2009 | US7566560 Polypeptides and expression vectors host cell and transgenic plants with nucleic acid and stress resistance; antifungal agent |
| 07/28/2009 | US7566558 Polyketide synthetase activity; vectors; host cells |
| 07/28/2009 | US7566555 Expressing in isolated animal cells a mutant tyrosyl-tRNA synthetase, Bacillus stearothermophilus suppressor tyrosyl tRNA, a gene encoding a desired protein comprising a nonsense mutation at a desired site |
| 07/28/2009 | US7566552 Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 07/28/2009 | US7566549 Using hapten derivatives for the preparation of antigens, antibodies and reagents for use detecting lysergic acid diethylamide (LSD) in samples; hallucinogen |
| 07/28/2009 | US7566545 Decreasing blood glucose levels in an animal or for preventing or delaying the onset of a rise in blood glucose levels; improving insulin sensitivity in an animal or for preventing or delaying the onset of insulin resistance; diabetes obesity |
| 07/28/2009 | US7566539 Anti-CCR2 antibodies and methods of use therefor |
| 07/28/2009 | US7566458 Influenza hemagglutinin and neuraminidase variants |
| 07/28/2009 | US7566453 Methods for treating melanomas |
| 07/28/2009 | US7566451 Human immunodeficiency virus-neutralizing human antibodies with improved breadth and potency |
| 07/28/2009 | US7566450 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulins for use in treatment and prevention of skin disorders |
| 07/28/2009 | US7566449 Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and β1 integrins |
| 07/28/2009 | US7566447 Biocides |
| 07/28/2009 | CA2316447C Rantes mutants and therapeutic applications thereof |
| 07/28/2009 | CA2148369C Actinobacillus pleuropneumoniae outer membrane lipoprotein a and uses thereof |
| 07/23/2009 | WO2009091994A2 Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof |